GREENVILLE, Pa.—Thiel College President Susan Traverso, Ph.D. discussed how the College might handle the release of a COVID-19 vaccine for the spring semester with a reporter for an area CBS affiliate Friday.
Traverso highlighted the College’s plans for the spring and how those might change if a vaccine is approved.
She mentioned the College will continue working with state and local health department officials to determine the best course of action.
“We are pacing ourselves to continue to live the way we have, successfully, with our masks on, keeping social distancing pretty much for the spring semester. And if distribution and implementation of the vaccine come faster, and we so hope it does, of course, we’ll make adjustments,” said Thiel College President Susan Traverso.
About Thiel College
Thiel College is an independent college founded in the Lutheran tradition. Located in Greenville, Pa., the College offers 60 majors and minors, 24 varsity sports, and an 11:1 student-faculty ratio. The College is also home to a new Master of Science in speech-language pathology and 2Master of Business Administration. Both master’s degree programs offer innovative and accelerated five-year paths which allow students to earn a bachelor’s and master’s degree in five years. The speech-language pathology program also has an accelerated 15-month graduate-level program. The M.B.A. program also has a 12-month post-graduate program.A dedicated faculty paired with dynamic research and internship opportunities produce numerous graduate school and job placements. Coeducational from its beginnings, the College remains committed to combining tradition with innovation as it celebrates 150 years.